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1. INTRODUCTION 
 
1.1. Epidemiology of Cystic Fibrosis 
Cystic fibrosis (CF) is the most common fatal inherited disease in the Caucasian popula-
tion, affecting about 1:2,500 children, with a carrier frequency of 1:25 [1]. CF is caused by 
mutations in a 230 kB gene on chromosome 7 encoding a 1480 amino acid polypeptide 
named cystic fibrosis transmembrane conductance regulator (CFTR) [2-4]. The disease is 
diagnosed on clinical symptoms including persistent cough and diarrhea caused by pancre-
atic insufficiency. The single most useful diagnostic procedure is the sweat test with chlo-
ride concentrations > 60mmol/L in typical cases of CF. Generally, the diagnosis is con-
firmed by genotyping of the most common CFTR mutations which vary between different 
geographic regions. Over 1,200 mutations and sequence variants have been described to 
date and reported to the Cystic Fibrosis Genetic Analysis Consortium [5]. Most of these 
mutations are rare and only 4 mutations occur in a frequency of more than 1%. CFTR mu-
tations are grouped into five classes: defective synthesis (I), defective processing (II), de-
fective regulation (III), defective conductance (IV) partially defective production or proc-
essing (V) [6]. Class I-III mutations are more common and associated with pancreatic in-
sufficiency. Patients with the rarer class IV-V mutations often are pancreatic sufficient. The 
most common mutation worldwide is a class II mutation caused by a deletion of phenyla-
lanine in position 508 (F508del) of the CFTR protein leading to misfolding. Of 43,849 CF 
chromosomes tested, 66% are F508del. Linking mutations to the severity of lung disease 
has been unsuccessful and patients who are homozygous for the F508del mutation exhibit a 
wide spectrum in the rate of development and severity of lung disease, suggesting the pres-
ence of modifier genes. Prognosis of CF has improved dramatically in some but not all 
countries as a result of better care and therapy and most children now reach adult life. 
 
1.2. Structure, Function and Localization of CFTR 
CFTR functions as a chloride channel in apical membranes [7, 8]. The primary structure 
of CFTR indicated that it belongs to a family of transmembrane proteins called ATP-
binding cassette (ABC) transporters [8, 9]. ABC transporters (or traffic ATPases) form a 
large family of proteins responsible for the translocation of a variety of compounds across  
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membranes of both prokaryotes and eukaryotes. CFTR is composed of five domains: 
two membrane-spanning domains (MSDs), two nucleotide-binding domains (NBDs), and a 
regulatory (R) domain (Fig. 1). The F508del mutation occurs in the DNA sequence that 
codes for the NBD1. In wild-type CFTR an extracellular glycosylation site is present and 
the NBDs and R domain are located on the intracellular side of the membrane 
 
Fig. 1. Schematic model of CFTR. MSD: membrane-spanning domain, NBD: nucleotide-
binding domain; R: regulatory domain. Also indicated is a putative nucleotide-binding do-
main. (from[10]). 
 
Based on its structural similarity to the family of ATP-binding cassette (ABC) trans-
porter proteins and its close association to intracellular signaling proteins and proteins of 
the cyto-skeleton, CFTR is involved in the regulation of other ion channels [11], signal 
transduction pathways, transmembrane trafficking of small organic molecules, cell division 
and apoptosis [12, 13]. 
In general, CFTR is found in tissues that are clinically affected by CF although low lev-
els also occur elsewhere. The most common site is in the apical membrane of epithelial 
cells that line exocrine ducts or airways, and this is consistent with the proposed chloride 
channel function [14-16]. By immunohistochemistry, wild type but not F508del CFTR was 
detected at the luminal membrane of crypt colonocytes, sweat glands, submucosal glands 
and respiratory epithelial cells. Both B and T lymphocytes express CFTR,  reveal abnormal 
chloride transport, although this seems to have little functional importance. No important 
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functional abnormalities have been shown in the heart or the placenta, both sites of CFTR 
expression, and the electrolytes of ocular humour, breast milk and seminal fluid are not 
significantly altered in CF.  
CF leads to pathologic changes in organs that express CFTR; therefore secretory cells, 
sinuses, lungs, pancreas, liver and reproductive tract are involved. The most dramatic 
changes are observed in CF airways where the basic defect causes mucus retention, chronic 
bacterial infection and inflammation. Lung infections with Pseudomonas aeruginosa con-
stitute a predominant disease phenotype in CF patients. Chronic bacterial lung infections 
are responsible for most of the morbidity and mortality in CF [17]. Infections with Staphy-
lococcus aureus and Haemophilus influenzae are also frequent. 
 
1.3. The Relation between CFTR and Lung Disease 
Several hypotheses have been offered to explain the failure of mucosal defense in the CF 
lung. One of these hypothesizes that inflammation precedes infection. Autopsy specimens 
from neonates with CF who have not yet developed lung disease show luminal dilation in 
submucosal glands [18]. This may indicate mucus accumulation. Indeed elevated viscosity 
has been detected in CF submucosal glands, which was interpreted to promoting bacterial 
colonization and airway disease in CF patients due to impaired mucociliary clearance and 
antimicrobial defense mechanisms [19]. Staining of immune cells revealed significant dif-
ferences between CF and non-CF fetal airways concerning the numbers of mast cells and 
macrophages [20]. Already in the first months of life inflammatory infiltrates in bronchi 
and mucopurulent plugging of airways can be detected histologically [21]. Both the number 
of neutrophils and levels of a neutrophil attracting  IL-8, were increased in bronchoalveolar 
lavage (BAL) of CF infants as young as 4 weeks who had negative cultures for common 
bacterial CF-related pathogens [22, 23]. How is neutrophil activation related to infection? 
Lysosomal enzyme release and enhanced production of reactive oxygen species may facili-
tate bacterial infection. The release of host proteases during acute and chronic inflamma-
tion may damage epithelial cells thereby faciliating P. aeruginosa adhesion in vitro and in 
vivo [23, 24].  
The notion that inflammation precedes bacterial lung infection is also supported by  cell 
culture studies, revealing increased toll-like receptor expression [25], increased NFkB acti 
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vation [26, 27] and increased baseline IL 8 production [27] in CF cells versus controls. 
Most of the uncertainties in this context derive from the fact that it is difficult generally 
start very early after birth in these patients. Only one study was reported which revealed an 
increased immune cell infiltration into the CF mucosa [28].  
Therefore, CF mouse models have been developed [29-31]. The expression of human 
CFTR in CFTR-/- mice under the control of the rat intestinal fatty acid-binding (FAB) pro-
tein gene promoter [31], resulted in prolonged survival of the animals and allowed to study 
CF-related lung disease more closely. Support of the hypothesis that inflammation precedes 
infection stems from a study in germ-free raised CF mice which showed signs of inflamma-
tion [32] and sterile fetal CF airways, transplanted into severe combined immunodeficiency 
mice [33, 34]. An increased IL-8 production and increased neutrophil infiltration was ob-
served (Fig. 2). Furthermore, long-lived C578L/6J CFTR-/- mice develop CF-like disease 
[35, 36] and are more susceptible to bacterial infection [37, 38]. CF like morphology such 
as defective mucociliary transport and neutrophilic inflammation in the absence of infec-
tion are also seen in mice oberexpressing the beta subunit of the epithelial sodium channel 
[39]. However, others groups have not confirmed some of these findings. Thus, in newly 
diagnosed CF infants under the age of six months [40], and in a group of CF patients up to 
48 months of age [41], inflammatory BAL markers correlated with the presence of infec-
tion and decreased when pathogens were eradicated. 
 
 9
 
 
 
Fig. 2. Murine leukocytes infiltrate into the lumen of long-term CF grafts. A: mature 
non-CF graft (gestational age, 16 wk; engraftment time, 15 wk) showing Ly5+ murine leu-
kocytes in the mesenchyme but not in the lumen of bronchiolar (br) and alveolar (al) areas. 
B: bright-field view of A. C: mature CF graft (16 + 15 wk) showing Mac1+ murine leuko-
cytes in the lumen of bronchioles (br). Note that some, but not all, luminal areas are infil-
trated with murine leukocytes. D: bright-field view of C. E: detail of mature CF graft (12 + 
28 wk) showing Gr1+ mouse neutrophils packed in the mesenchyme (m), epithelium (e), 
and bronchiolar lumen (br). F: bright-field view of E. Scale bars: 200 µm in A and B, 100 
µm in C and D, and 50 µm in E and F (from [34]).  
 
 
Several other hypotheses have been offered to explain the failure of mucosal defense 
and the high prevalence of P. aeruginosa in the CF lung. It has been proposed that P. 
aeruginosa binds to CF airway epithelial cell membranes in higher density than to respec-
tive cells 
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 from normal individuals due to an increased P. aeruginosa asialo-GM1 receptor density 
[42, 43]. The higher bacterial number would then lead to infection in CF airways. Other 
studies, however, reveal that both P. aeruginosa and S. aureus are located in the mucus 
layer on respiratory epithelial cells rather than directly on cell membranes and that no dif-
ference in location and number of adhering bacteria is visible regardless whether normal or 
CF primary respiratory cells are used, or infected CF lung tissue is investigated for P. 
aeruginosa or S. aureus adhesion [44, 45]. Alternatively, also wild type CFTR (but not 
mutated CFTR) has been shown to be a receptor for P. aeruginosa which mediates bacte-
rial cell internalization and P. aeruginosa killing. In CF airways, therefore, P. aeruginosa 
would not be eradicated intracellularly and could multiply and cause infection [46]. Addi-
tionally, based on the assumption of an increased sodium chloride concentration due to a 
defective CFTR channel on the luminal side of the respiratory epithelium, it has further-
more been suggested that salt sensitive cationic antimicrobial peptides (defensins) are inac-
tivated in the airway surface liquid (ASL) of CF patients which would lead to bacterial 
multiplication and subsequent infection [47]. However, not all defensins are salt-sensitive 
and it has been difficult to prove that the ASL in CF is indeed hypertonic. In contrast, most 
in vivo data reveal that the ASL from normal and CF individuals is isotonic [48].  
The hypothesis of defective mucociliary clearance in CF airways is based on the as-
sumption that chloride secretion into the airway surface liquid is inhibited by mutated 
CFTR, leading to sodium hyperabsorption, leaving the luminal site hypotonic. To establish 
isotonic conditions, increased water absorption occurs from the luminal site which leads to 
a volume/height depletion of the airway surface liquid, resulting in mucus stasis [48, 49]. 
The higher viscoelasticity of the CF mucus layer and submucosal gland secretions may also 
influence innate immunity functions within these areas [50, 51].  
 
1.4. Natural killer T cells 
 Given the evidence that inflammation precedes infection in CF, the possibility arises 
that natural killer T (NKT) cells may recognize the abnormal cells in organs which express 
altered CFTR or lack CFTR. NKT cells are a specialized subset of T lymphocytes which 
express a very limited T cell receptor (TCR) repertoire, consisting of an invariant TCRα 
chain (murine: Vα14Jα18) and a restricted, yet not invariant TCRß (Vβ11) repertoire [52- 
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54]. Most NKT cells are characterized by the co-expression of the NKT cell surface 
marker, NK1.1, and an antibody directed against the T cell receptor.  
NKT cells react to several glycolipide antigens presented by the MHC class I-like mole-
kule, CD1d on antigen presenting cells [55-58]. One of these, isoglobotrihexosylceramide 
(iGB3) is an endogenous lysosomal glycosphingolipd, derived from lysosomal degradation 
of iGB4 via β-hexosaminidase [56] (Fig. 3). ß-hexosaminidase removes the terminal Gal-
Nac of iGb4 in the lysosome to produce iGb3. The α-galactosidase A transforms subse-
quently iGb3 into lactosylceramide.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3. An antigen for NKT cells. The TCR of NKT cells recognizes the glycosphingolipid 
iGb3 presented in the context of CD1d. Recognition of iGb3 occurs during NKT cell selec-
tion in the thymus (top) and activation in the periphery (bottom). Loading of iGb3 into 
CD1d first requires biosynthesis of the isoglobo-series glycosphingolipids and the subse-
quent degradation of these molecules in lysosomes by the enzymes ß-hexosaminidase A 
and B (box) (from ref [59]).  
 
 
Natural killer cells release Th1 cytokine such as γ-IFN and TNFα,  but also Th2 cyto-
kines such as IL-4, IL-10 and IL-13. The production of TH1 and TH2 cytokines from NKT 
cells are thought to be important for suppression of autoimmunity, promotion of tumor im 
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munity and suppression of allergy and inflammmation [60, 61] (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Schematic diagram of Vα14 NKT cell activation and their interactions. Two types 
of activation pathways, through innate immune system/IL-12 receptor and through specific 
recognition of the ®-GalCer ligand, are represented. Each activation pathway displays dif-
ferent functional activities of V®14 NKT cells. TLR, Toll-like receptor; APC, antigen  
presenting cells; LPS, lipopolysaccharide; LAM, lipoarabinomannane; M, macrophage 
(from [61]).  
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1. 5. Aim of the study 
Based on the notion that inflammation may precede infection in CF, the aim of the study 
was to investigate whether the CF defect would be recognized by cells of the innate im-
mune system. Specifically, uninfected CF mouse strains and the respective wild type strains 
of different ages should be used to locate and quantify NKT cells, macrophages and neu-
trophils and other immunocompetent cells in organs which express CFTR. A second aim of 
the present study was to test the hypothesis that ceramide accumulates in lung of CFTR-/- 
mice.  
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2. MATERIALS AND METHODS 
2.1   Chemicals, reagents und buffer    
 
Ethanol                       (Merk, Darmstadt) 
Xylene                         (Merk, Darmstadt) 
Tween 20                  (Sigma, Deisenhofen) 
Solvent resistant Pen                                          (DAKO, Hamburg) 
Cover slip                                                                  (R. Langenbrinck, Emmendingen) 
Hämatoxylin         (Sigma, Deisenhofen) 
Formaldehyde        (Sigma, Deisenhofen) 
Hydrogen peroxide 3%      (Sigma, Steinheim, Germany) 
Chem Mate-Target Retrieval Solution x10                    (DAKO Hamburg)   
Aceton                                                                                               (Merk, Darmstadt) 
Proteinase K                (DAKO Hamburg) 
     AEC Peroxidase Substrate Kit                  (Vector Laboratories) 
Vector Nova Red Substrate Kit                 (Vector Laboratories) 
Fluorescent Mounting Medium                         (DAKO Hamburg) 
     Faramount, Aqueous Mounting Medium                        (DAKO Hamburg) 
     Fisher Superfrost slide          (R. Langenbrinck, Emmendingen) 
BCIP/NBT Substrate                                                                         (Vector Laboratories) 
 
2.2 Media 
2.2.1 Phosphate-Buffered Saline (PBS) x 20 
           85, 00 g NaCL  
           14, 23 g Na2HPO4 x12 H2O 
           1, 35 g KH2PO4 
           1, 00 g NaN3 
           Mix in 500 ml distilled water. 
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2.2.2 PBS-Tween  
Dilute PBS x 20 1:20 in 1 l distilled water and mix with 2 ml Tween 20. 
 
     2.2.3 Formaldehyde 4% 
Dilute formaldehyde 37%   1:9 with distilled water and store at 4°C. 
 
2.2.4 Triton X 100/Tween 
Dilute Triton X 100 1:200 in PBS-Tween. 
 
2.2.5 Chem Mate (Target Retrieval Solution) 
Mix 180 ml distilled water and 20 ml Chem Mate solution. 
 
2.3 Mouse strains. The following mouse strains with C57Bl/6NCrl background were used. 
(Table 1). Anna M. van Heeckeren, Case Western Reserve University, Cleveland, USA 
provided CF mice with a S489X mutation in CFTR. Hugo de Jonge, Erasmus University, 
Rotterdam, The Netherlands, provided CF mice with a F508 deletion in CFTR. Uta 
Griesenbach, Imperial College London, England, provided gut-corrected FABp CF mice on 
UNC-Null background, originally made by Jeff Whitsett.  The same CF strain, treated with 
the ASMase blocker amitryptilin was provided by Erich Gulbins, Institut für Molekular-
biologie, Universitätsklinikum Essen. Erich Gulbins also provided a CFTR-/-ASM-/- dou-
ble mutant mouse strain.   
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Table1. Age, number, genotype and origin of mice, used in the study. 
    
Age Sample # Section 
# 
 
Mause # CFTR 
genotype 
++ 
CFTR 
genoty-
pe -/- 
CFTR 
-/-
ASM 
-/- 
  A1 
10 4 48 4 42 0  0 
12 18 216 18 93 93  0 
14 4 48 42 42 0  0 
18 4 48 4 0 42  0 
22 3 36 3 0 0 34 0 
24 4 36 4 42 0 0 0 
28 24 240 24 24 142 0 84 
30 10 120 10 0 252 0 54 
34 12 72 2 15 15 0 0 
52 18 216 18 62 62 0 64 
 
1: CFTR -/-, Amitriptyline; 2: from Uta Griesenbach; 3: from Anna M. van Heeckeren; 4: 
from Erich Gulbins; two CFTR+/+ mice, 28 week old were infected with P. aeruginosa; 5: 
from Hugo de Jonge.  
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2.4 Antibodies, used for cell characterization in the study.  
________________________________________________________________________ 
Monoclonal antibody to ceramide       (Alexis)  
Monoclonal antibody to mouse CD68      (Acris) 
Monoclonal antibody to mouse neutrophils      (Acris) 
Monoclonal antibody to mouse NKG2D      (R&D System) 
Monoclonal antibody to mause CD3e      (R&D System) 
Monoclonal antibody to mause NK1.1      (eBioscience) 
Monoclonal antibody to mause CD4       (eBioscience) 
Monoclonal antibody to mause CD25      (eBioscience) 
Cy2 conjugated Goat antibody to Rabbit IgG (H+L)    
 (Dianova)* 
Cy2 conjugated Goat antibody to Syrian Hamster IgG (H+L)   (Dianova)* 
Cy2 conjugated Goat antibody to Rat IgG (H+L)     (Dianova)* 
Cy2 conjugated Goat antibody to maus IgG (H+L)     (Dianova)* 
Cy3 conjugated Goat antibody to Rat IgG (H+L)     (Dianova)* 
Cy3 conjugated Goat antibody to maus IgG (H+L)     (Dianova)* 
Cy3 conjugated Goat antibody to Rabbi IgG (H+L)     (Dianova)* 
________________________________________________________________________ 
*: Second antibody 
 
2.5 Immunofluorescence staining of murine tissues. Staining of murine tissues was done 
by indirect immunofluorescence using different antibodies (table) as described previously 
by Ulrich et al. [44].  
1. Prepare cryostat thin sections (5–10 µm) (Kryostat 2800 Frigocut E; Reichert-Jung,         
Heidelberg, Germany) from shock-frozen lung tissue material.  
2. Fix thin sections on cover slips with acetone for 5 min.  
3. Wash cover slips with PBS-Tween for 15 min. 
4. Preincubate cover slips with normal goat serum, 1:10 diluted in PBS-Tween for 30          
min.  
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5. Wash 3X with PBS-Tween for 5 min   
6. Incubate with first antibody in respective dilutions in Triton 0, 5% for 1 h at room           
 temperature or overnight at 4° C  
7. Wash 3X with PBS-Tween for 5 min  
8.  Incubate with second antibody Cy2-labeled in respective dilutions in Triton 0, 5% for    
 1 h at room temperature  
9. Wash 3X with PBS-Tween for 5 min  
10. Incubate with DAPI 1:500 in PBS-Tween for 5 min at room temperature  
11. Wash 3X with PBS-Tween for 5 min   
12. Embedd with Fluorescent Mouting Medium and cover slip (24 x 60 mm) 
13. Store in refrigerator at 4°C before microscopic examination 
 
2.6 PAS staining of murine lung tissue.  
 
1. Wash tissue sections 1– 15 min in PBS-Tween  
2. Incubate sections with periodic acid for 5 min. 
3. Wash with distilled water  
4. Incubate sections with Schiff’s reagent for 15 min.  
5. Wash with warm water (20-25°C)   
6. Stain with Hematoxylin for 1 min. 
7. Wash with water for 5 min  
8. Embedd with DAKO Faramount Aqueous Mouting Medium and cover slips (24 x 60      
   mm). 
9. Store in refrigerator at 4°C overnight before microscopical examination. 
 
2.7 Immunohistochemistry staining of murine tissues. Staining of murine tissues was 
done by indirect immunohistochemistry using different antibodies (table) as described pre-
viously by Ulrich et al. [44]. 
 
1. Prepare cryostat thin sections (5–10 µm), (Kryostat 2800 Frigocut E; Reichert-Jung,        
 Heidelberg, Germany) from shock-frozen lung tissue material.  
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2. Fix thin sections on cover slips with acetone for 5 min.  
3. Wash cover slips with PBS-Tween for 15 min. 
4. Preincubate cover slips with Endogenous Alkaline Phosphatase Inhibitor 15 min.  
5. Wash 3X with PBS-Tween for 5 min.  
6. Preincubate cover slips with normal goat serum, 1:10 diluted in PBS-Tween for 30          
min.  
7. Wash 3X with PBS-Tween for 5 min .  
8. Incubate with first antibody in respective dilutions in Triton 0.5% for 1 h at room tem-
perature or overnight at 4° C  
9. Wash 3X with PBS-Tween for 5 min.   
10. Incubate with second antibody APAAP-labeled in respective dilutions in Triton   0.5     
  % for 1 h at room temperature. 
11. Wash 3X with PBS-Tween for 5 min.  
12. Incubate with BCIP /NBT Substrate 20 min at room temperature.  
13. Wash 3X with PBS-Tween for 5 min. 
14. Incubate with Hämatoxylin for 1min. 
15. Wash 3X with PBS-Tween for 5 min. 
16.  Embedd with Aquous Mouting Medium and cover slip (24 x 60 mm). 
17.  Store in refrigerator at 4°C before microscopic examination. 
 
2.8. Statistics. To calculate statistically the numbers of immune cells in mouse tissues the 
Student’s t-test was applie, using Microsoft Excel 0.5.  
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3. RESULTS 
 
3.1 Acccumulation of NKT cells in submucosal glands of CFTR-/- mice.  
Based on the hypothesis, that cells expressing mutated CFTR (or cells which do not ex-
press CFTR at all) are recognized by the innate immune system, lung tissue of CFTR-/- 
mice was stained for NKT cells using NK1.1 and CD3 antibodies. A clustering of NKT 
cells was observed in CFTR-/- mice (Fig. 5 A, C), in contrast to the lung tissue of wild type 
(WT) mice (Fig. 5 B, D). NKT cell accumulated in areas of submucosal glands of CFTR-/- 
mice, identified by PAS staining (E) in subsequent tissue sections. Submucosal glands of 
WT mice did not show this accumulation.  
            CFTR-/-              WT  
           
 B  
 
 
 
 
 
 
   
 
 
 
 
        
 
 
 
 
 
Fig. 5. NKT cells accumulate around submucosal glands in 12 weeks old CFTR-/- mice. 
Sequential tissue sections were stained for NKT cells with the mABs NK1.1 (A, B) and CD3 
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(C, D), followed by a second antibody, coupled to Cy3 (A, B) and Cy2 (C, D). Submucosal 
glands (arrow) were identified by PAS staining in CFTR-/- mice (E) and wild type (WT) 
mice (F). l: lumen of the bronchi; m: mucosal tissue; P: NKT cells; sm: submucosal tissue. 
Color change between E and F is a result of the tissue structure. Original magnification: 
400X .  
 
 
Another example supporting the co-localization of NKT cells with submucosal glands in 
12 weeks old CFTR-/- mice is shown in Fig. 6.   
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. NKT cells accumulate around submucosal glands of 12 week old CFTR-/- mice. 
NKT cells (arrow) were stained with the mAB NK1.1 (A) and CD3 (C), followed by a sec-
ond antibody, coupled to Cy3 and Cy2. D: superposition of A and C with DAPI stain for cell 
nuclei. B: PAS-stained submucosal gland (g; arrow) of a subsequent tissue section. Original 
magnification: 400X .  
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When the number of NKT cells was counted in tissue sections of CF and WT mice, a 
significant increase in NKT cell numbers was observed in 12 weeks old CFTR-/- mice 
compared to WT mice (Fig. 7) (p=0.0006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. NKT cells are increased in lung tissue of 12 weeks old CFTR-/- mice. Fluores-
cent labeled NKT cells were counted in lung tissue sections of 4 wild type (WT) and 4 CF 
mice. Values (◊) represent means of NKT cells counted in 4-10 single tissue areas per 
mouse. 
 
 
 
 
 
3.2 NKT cell accumulation progresses with the age of CFTR-/- mice. 
Significant clustering of NKT cells were also detected in 28 weeks old CFTR-/- mice 
(Fig 8 A, C, G), but not in normal mice (Fig. 8 B, D, H). NKT cells were located around 
submucosal glands, identified by PAS staining (I) in subsequent tissue sections. Again, 
submucosal glands of WT mice did not show this accumulation. Submucosal glands of 
CFTR-/- mice were enlarged (I) in comparison to WT mice and increased in numbers (data 
not shown). 
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Fig. 8. NKT cells numbers increased around submucosal glands in 28 weeks old CFTR-
/- mice. NKT cells were stained with the monoclonal antibody NK1.1 (A, B) and CD3 (C, 
D), followed by a second antibody, coupled to Cy3 (A, B) and Cy2 (C, D). Cell nuclei were 
stained with DAPI (E, F). G, H: superposition of A, C and E, and B, D, F, respectively. 
Submucosal glands (arrow) were identified by PAS staining in CFTR-/- mice (I) and 34 
week old wild type (WT) mice (J). l: lume of the bronchi; bv: blood vessel; lm:  Lymphocyte 
aggregates in respiratory submucosal glands. Original magnification: 400X  
 
When the number of NKT cells was counted in tissue sections of CF and WT mice, the 
increase in NKT cell numbers was even higher than that observed in 12 weeks old CFTR-/- 
mice (Fig. 9), suggesting that the CF defect triggers a progressive innate immune response 
(p=0.0003). 
 
 
 
 
 
 
   
 
 
 
 
 
Fig. 9. NKT cells expression is progressive with the age in CFTR-/- mice. Fluorescent 
labeled NKT cells were counted in lung tissue sections of 12 weeks and 28 weeks old 
CFTR-/-. Values (◊) represent means of NKT cells counted in 4-10 single tissue areas per 
mouse. Four mice per age were investigated. 
 
This notion was further corroborated when different sections of lung tissue of 12 week 
and 28 week old CFTR-/- mice was stained for NKT cells (Fig. 10). In 12 week old CFTR-
/- mice,  NKT cells were localized around submucosal glands of bronchi, but not in smaller 
bronchioli (Fig. 10 B), whereas in 28 week old CFTR-/- mice, NKT cells were also seen in 
the periphery of the lung including alveolar septa (Fig. 10 A). In the 28 week old mice, 
particularly high NKT cell numbers were present in areas of bronchial divisions (Fig 10 C-
F).  
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Fig. 10. NKT cells in periphery and in areas of bronchial divisions in 28 week old 
CFTR-/- mice. NKT cells were stained with the mAB NK1.1 and a second antibody, coupled 
to Cy3 (A, B, C) and with a mAB to CD3 and and by a second antibody coupled to Cy2 (D). 
Cell nuclei were stained with DAPI (E). F: superposition of C, D, and E. NKT cells were 
identified (arrow) in 28 week old CFTR-/- mice (A), but not in 12 week old CFTR-/- mice 
(B) and particularly high NKT cell numbers were present in the area of bronchial divisions 
B1, B2, B3 (arrows) of the upper lobe bronchi of 28 week old CFTR-/- mice (C-F). la: Lym-
phocyte aggregates. Original magnification:100X.  
 
3.3. Accumulation of macrophages and neutrophils in CFTR-/- mice.  
Activated mouse Vα14 NKT cells rapidly secret cytokines and chemokines, particularly 
interferon γ (INF- γ) and IL-4, supporting T helper 1 (TH1) cell differentiation at an early 
stage and TH2 cell development at a later stage [52, 53, 60, 61]. To investigate whether 
NKT cell activation leads to the influx of macrophages and/or neutrophils, we stained lung 
tissue of CFTR-/- mice and controls for these effector cells. An increase in macrophage cell 
numbers was observed in the submucosa of CFTR-/- mice (Fig. 11 A, C). Only marginal 
macrophage numbers were present in WT mice (Fig. 11 B, D). 
                                                                   
         CFTR-/-                                                        WT  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
  
  C D 
A B 
 27
Fig. 11  Acumulation of macrophages in submucosal lung tissue of 32 week old CFTR-/- 
mice. Macrophages (arrow) were stained with a mAB to murine CD68, followed by a sec-
ond antibody, coupled to Cy2 (A, B), or stained with DAPI for cell nuclei (C, D). Macro-
phages were highly increased in CFTR-/- mice (A), compared to 52 week old wild type (WT) 
mice (B). Original magnification: 100X.  
. 
 
Similar results were observed when neutrophils were stained (Fig. 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  12.  Accumulation of neutrophils in the lung submucosa in 30 week old CFTR-/- 
mice. Neutrophils (arrow) were stained with a rat anti-mouse neutrophil antibody, fol-
lowed  by a second Cy2-coupled anti- rat antibody (A) or stained with DAPI for cell nuclei 
(B). Neutrophils were highly increased in CFTR-/- mice, compared to wild type mice (not 
shown; see fig. 14). Original magnification:100X. 
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To rule out that the observed macrophage/neutrophil clustering in the submucosa of 
CFTR-/- mice was due to lung infection, P. aeruginosa-infected C57Bl/6 wild type mice 
were stained for macrophages (Fig 13). Macrophages were predominantly clustering in the 
lung epithelium and in the airway lumen, however not observed in the submucosa.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. Macrophage cluster-
ing in the lung epithelium of 28 
week old P. aeruginosa-infected 
wild type (WT) mice. Macro-
phage (arrows) were stained with 
an mAb to murine CD68, fol-
lowed   by a second antibody, 
coupled to Cy2 (A) or stained 
with DAPI for cell nuclei (B). 
Macrophages were highly in-
creased in the epithelium of P. 
aeruginosa-infected WT mice, but 
not in the submucosal tissue. m: 
mucosa; sm: submucosal tissue. 
Original magnification:100X. 
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In CFTR-/- mice, macrophage (p<0.0001) and neutrophil (p=0.0015) numbers increased 
with the age of the animals and were significantly different from these cell numbers in WT 
mice 52 weeks of age (Fig. 14).          
            
                             CFTR-/-                                                      WT 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
                       CFTR-/-                                                      WT 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 14. Macrophage and neutrophil numbers increased with the age of CFTR-/- mice. 
Fluorescent labeled macrophages (A, B) and neutrophils (C, D) were counted in lung tissue 
sections of CFTR-/- mice and wild type (WT) mice of different ages.The number of macro-
phages significantly differed between CFTR-/- at 28 weeks of age and WT mice at 52 
weeks of age. Neutrophil numbers were significantly different between the two groups at 
52 weeks of age. Values (◊) represent means of Macrophages or neutrophils counted in 4-
10 single tissue areas per mouse. A: 21 mice; B: 13 mice; C: 17 mice; D: 12 mice were 
investigated. 
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3.4. Acumulation of ceramide in lung tissue of CFTR-/- mice. 
Since NKT cells recognize endogenous glycosphingolipids, such as isoglobotrihexosyl-
ceramide (iGb3) [56, 57], presented by the MHC class I-like CD1d protein, lung tissue sec-
tions of CFTR-/- mice and controls were stained with an antibody against ceramide. In-
deed, in lung tissues of CFTR-/- mice, significantly increased concentrations of ceramide 
were expressed in the area of mucosal tissue (epithelium) and submucosal glands (Fig. 15 
A) and in the periphery (not shown) compared to control tissues (Fig. 15 B).  
 
 
 
 
      
     
 
 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
Figure 15.  Significantly 
increased concentrations of 
ceramide were present in 
mucosa and submucosal 
glands of CFTR-/- murine 
lungs. Ceramide (black ar-
eas, arrows) was stained 
with a mAB to ceramide in 
CFTR-/-mice (A) and wild 
type (WT) mice (B) followed 
by a second antibody, cou-
pled to an anti-maus anti-
body-coupled to PAAP. m: 
mucosa; sm: submucosal 
tissue.Original magnification: 
600X. 
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3.5 Amitriptyline reduces ceramide expression and NKT cells in CFTR-/- mice. 
To prove that the age-dependent NKT cell recruitment in CFTR-/- mice is correlated to 
ceramide overexpression, amitriptyline was intraperitoneally administered to CFTR-/- mice 
for 48 h before ceramide and NKT cell staining. Amitriptyline blocks acid sphingomyeli-
nase (ASMase) which by cleaving sphingomyelin produces ceramide in cell membranes 
[62]. A significant reduction of ceramide (Fig. 16) and NKT cells (Figs. 17, 18) was ob-
served in the lung tisues of 28 to 52 week old CFTR-/- mice (p=0.0002). 
 
 
          -Amitriptyline                                             + Amitriptyline 
 
                                               
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Amitriptyline reduces ceramide expression in the lung mucosa of CFTR-/- 
mice.  Ceramide (arrows) was stained with a mAB to ceramide in untreated (A) and 
amitriptyline treated (B) CFTR-/-mice, followed by a second antibody coupled to PAAP. 
m: mucosa; sm: submucosa; l: lumen of the bronchi. Original magnification: 600X. 
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        -Amitriptyline                                              + Amitriptyline 
 
 
 
 
 
 
 
 
 
 
 
                                                               
 
 
 
 
 
 
 
 
 
 
Fig. 17. Amitriptyline reduces NKT cell numbers in the submucosa of 28 week old 
CFTR-/- murine lungs. NKT cells were stained with the mAB NK1.1 (A, B), followed by 
a second antibody, coupled to Cy3, or stained with DAPI (C, D). Numbers of NKT cells 
(arrows) decreasead in amitriptyline treated CFTR-/- mice (B), compared to untreated 
CFTR-/- mice (A). Original magnification: 100X. 
.  
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Furthermore, clustering of NKT cells around submucosal glands was not any more present 
in amitriptyline treated CFTR-/- mice. When NKT cells were counted in amitriptyline 
treated and untreated 28 week old CFTR-/- mice, NKT cells decreased significantly 
(p=0.0002). (Fig. 18). Similar results were observed when macrophages were stained in 
CFTR-/- amitryptilin treated mice (Fig. 18) (p=0.001). In contrast, CD4+ T cells did not 
decrease (Fig. 24) (p=0.19). Taken together these findings demonstrate a correlation be-
tween defective CFTR expression, increased ceramide expression and increased NKT cell 
recruitment. 
 
 
 
 
 
 
 
 
 
 
    
Fig. 18. Amitriptyline decreases NKT and macrophage cell numbers in 28 week old 
CFTR-/- mice. Fluorescence-labeled NKT cells and macrophages were counted in lung 
tissue sections of amitriptyline treated and untreated CFTR-/- mice. A significant difference 
was found for NKT cells (p=0.0002) and macrophages (p=0.001). Values (◊) represent 
means of NKT cells or macrophages, counted in 4-10 single tissue areas per mouse. For 
NKT cells 9 mice, for macrophages 8 mice were investigated. 
 
 
 3.6. Acccumulation of NKT cells in intestinal tissues of CFTR-/- mice.  
Since the CF defect is also expressed in pancreas, liver and the intestinal tract, the re-
spective tissues derived from 34 week old CFTR-/- and the respective wild type mice were 
stained for NKT cells (Fig. 19). High NKT cell expression was observed in the mucosal 
lamina propria of jejunum (A), ileum (C) and colon (E) of CFTR-/- mice but not in the 
respective tissues of control mice (B, D, F). The results further suggest that the observed 
NKT cell recruitment in CFTR-/- mice is correlated to the basic CF defect. Increased cell 
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numbers of macrophage, neutrophils, NK cells, CD4+ or CD25+ lymphocytes were not 
observed in the 34 week old CFTR-/- mice in the investigated intestinal tissues (not 
shown).    
                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19.  High NKT cell expression in the mucosal lamina propria of jejunum, ileum 
and colon of 34 week old CFTR-/- mice. NKT cells were stained with the mAB NK1.1 
(A-F), followed by a second antibody, coupled to Cy3. Original magnification:100X. 
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Fig. 20.  High NKT cell expression in the mucosal lamina propria of jejunum of 34 
week old CFTR-/- mice (A-C) compared to wild type mice (D). NKT cells were stained 
with the mAB NK1.1, followed by a second antibody, coupled to Cy3 (A) or an mAB 
against CD3, followed by a second antibody, coupled to Cy2 (B). C: superposition of A  
and B plus DAPI staining. D: superposition of wild type staining using mAB to NK1.1 and 
CD3 as in A and B plus DAPI staining. Original magnification:1000X .  
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3.7 Accumulation of other immunocompetent cells in respiratory submucosal glands 
of CFTR-/- mice.  
Whereas in 12 week old WT mice minimal CD4+ T cells were present, this cell type 
was increased in 12 week old CFTR-/- mice (Fig. 21). PAS staining revealed that the cell 
accumulation was located around submucosal glands (Fig. 21 C, D).  Similar differences 
were observerd regarding CD25+ T cells (not shown). No difference in cell numbers was 
observed with regard to NK cells between WT and CFTR-/- mice (data not shown).  
 
                 CFTR -/-                                                                   WT 
 
 
 
 
 
 
 
 
 
                                                                               
 
 
 
  
 
 
 
 
Fig. 21. CD4+ T cells were present in 12 weeks old CFTR-/- mice. CD4+ T cells were 
stained with mAB to CD4, followed by a second antibody coupled to Cy2 (A, B). Glands 
(g) were stained with PAS (C, D). CD4+ T cells (arrow) were increased around submuco-
sal glands in 12 week old CFTR-/- mice (A, C), compared to wild type mice (B, D). Origi-
nal magnification: 400X. 
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As with NKT cells and macrophages, the numbers of CD4+ and CD25+ T cells were 
further increased in 28 week old CFTR-/- mice (Fig. 22). Particularly high CD4+ and 
CD25+ T cells numbers were present in areas where bronchial lobes devide. Amitriptyline 
had no influence on CD4+ cell numbers (Fig. 23) (p=0.19).  
              CD25      CD4 
 
           
 
 
 
 
 
 
 
Fig. 22 Accumulation of CD25+ and CD4+ T cells in the respiratory submucosa of 28 
week old CFTR-/- mice.  CD25+ and CD4+ T cells (arrows) were stained with specific 
mABs,  followed  by a second antibody, coupled to Cy2+. Sections were also stained with 
DAPI for cell nuclei. CD25+ and CD4+ T cells were high increased around submucosal 
glands compared to wild type mice (data not shown). l: lumen of the bronchi; sm: submu-
cosal tissue.  Original magnification: CD25 400X; CD4+T cells100X. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23.  Amitriptyline has no impact on CD4+ T cells numbers in 28 week old CFTR-
/- mice. Fluorescence labeled CD4+ T cells were counted in lung tissue sections of 28 
weeks old untreated and amitriptylin treated CFTR-/-. No significant differences were seen 
(p=0.19).  
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3.8.  Lymphocyte aggregates are present around respiratory submucosal glands of 
CFTR-/- mice. 
The described accumulation of cells of the innate immune system (NKT cells, macro-
phages, neutrophils) and the acquired immune system (CD4+, CD25+ T cells) represents a 
Lymphocyte Aggregate (LA) (Fig. 24). The LA was localized by immunofluorescent stain-
ing in the lung tissue of CFTR-/- mice, predominantly around submucosal glands, but not 
in normal WT mice (Fig. 25).  Additionaally, LAs were present in the area of bronchial 
divisions suggesting a concerted action, possibly directed against the basic defect in CF, 
i.e., mutated or absent CFTR. LAs were not observed in normal mice, regardless of their 
age.  
 
 
                    CFTR-/-                                                                     WT 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24 Several Lymphocyte Aggregates (LA) were present in submucosal lung tissues 
of 28 week old CFTR-/- mice. Lung tissue sections of 28 week old CFTR-/-mice (A) and 
52 week old wild type (WT) mice (B) were stained with DAPI for cell nuclei. The LAs 
were present in CFTR-/- mice (A), but not in wild type mice (B). b: bronchi.; bv: blood 
vessel. Original magnification: 100X. 
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Fig. 25 Lymphocyte Aggregates (LA)  in lung tissue of CFTR-/- mice. Subsequent sec-
tions of a CF mouse were stained with mAB against NKT cells (A), macrophages (B), 
CD4+ T cells (C) and NK cells (D). Original magnification:100X. 
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4. DISCUSSION 
   
The data of the present study demonstrate first the first time a correlation between defec-
tive CFTR expression, increased ceramide expression and an increased recruitment of cells 
of the innate and adaptive immune system in CF mouse strains. CFTR has been demon-
strated to be primarily expressed in submucosal glands of human airways [14] and it is pre-
dominantly around submucosal glands that high ceramide expression and aggregation of 
immunocompetent cells including NKT cells was observed in different CF mouse strains 
(Fig. 5, 6, 8, 15). In addition, NKT cell numbers were highly increased in intestinal tissues 
of CF mice which express CFTR (Fig. 19, 20). Furthermore, ceramide and NKT cells were 
significantly increased in the periphery of the lungs of CFTR-/- mice (Fig. 10 B).  
Why ceramide expression is abnormally high in CF tissues is unclear. Ceramide is syn-
thesized through a de novo pathway involving serine palmitoyl-CoA transferase and cera-
mide synthase or from membrane sphingomyelin breakdown by the secretory isoform of 
neutral and acid sphingomyelinase (ASMase) [62]. It has multiple biochemical effects in-
cluding the stimulation of apoptosis [63]. Indeed, by blocking ASMase with amitriptyline, 
ceramide concentrations decreased in lung tissues of CFTR-/- mice (Fig. 16).  
The observation that amitriptyline treatment of CFTR-/- mice, in addition to ceramide 
reduction, also significantly resolved NKT cell accumulation and reduced NKT cell num-
bers (Fig. 17), suggests a link between ceramide and NKT cells. NKT cells recognize ex-
ogenous and endogenous glycolipids, presented by the MHC class I-like CD1d protein via 
their conserved, semi-invariant Vα14-Jα18/Vß8 TCR [54-59] (Fig. 3). Structural studies 
reveal, that the ceramide tail of various glycolipids fits perfectly in the binding groove of 
CD1d [54]. It is intriguing to speculate that the observed ceramide accumulation in tissues 
of CF mice is indeed an accumulation of a self lipid antigen containing ceramide, whose 
carbohydrate component is unknown. A candidate for such a self glycolipid antigen is iso-
globotrihexosylceramide (iGb3) (Fig. 3), which has been suggested to be primarily recog-
nized by NKT cells in mice and men [56, 57].  
A link to the existing notions concerning the CF pathophysiology may relate to early 
studies showing that glycoconjugates from respiratory epithelial cells of CF patients were 
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more sulfated and fucosylated and undersialylated than respective control glycoconjugates 
[64-66]. These abnormalities have been explained as a consequence of defective acidifica-
tion of the trans-Golgi network in CFTR expressing cells [67]. A more basic pH could 
modify the activity of glycosyltransferases leading to the observed changes [68]. However, 
also a shift to a more acidic pH could result in in undersyalylation of glycoconjugates. In-
deed, hyperacidification of endosomal organelles in CF lung epithelial cells has been dem-
onstrated [68] and explained as a consequence of diminished CFTR inhibition on sodium 
transport [69]. The internal pH values in CF cell lines at pH 6.0 were 0.7 and 0.6 pH units 
lower than in corrected cell lines (P0=0.0001) [69]. Lysosomal hyperacidification may pos-
sibly affect also the enzymes which degrade glycosphingolipids. Provided that α-
Galactosidase A is inhibitied, an accumulation of iGb3 may occur which would be attrac-
tive for NKT cells (Fig. 3). The present study opens the possibility to test the hypothesis 
that ceramide is linked to glucose and galactose to form iGb3, and if so, to determine the 
concentration of iGb3 in intestinal tissues of CF mouse strains and compare it with that in 
normal murine intestine. 
In parallel with the increase of NKT cell numbers with increasing age of CFTR-/- mice 
(Fig. 9), an age-dependent significant increase in macrophage and neutrophil cell numbers, 
present at submucosal glands in the respiratory tract of CFTR-/- mice was observed (Fig. 
14). Since activated Vα14 NKT cells produce large amounts of cytokines within hours of 
primary stimulation and can drive immune responses in both pro- and anti-inflammatory 
directions [52, 53, 61] (Fig. 4),  it is possible that the age-dependent increase of macro-
phages and neutrophils is due to the increased NKT cell numbers. However, it is equally 
possible that these effector cells are attracted to non-functional CFTR cells in an NKT cell-
independent manner. Nevertheless, normalization of ceramide expression in amitryptilin 
treated CFTR-/- mice which reduced NKT cell, macrophage and neutrophil numbers and 
prevented their accumulation around submucosla glands significantly, support the link be-
tween NKT cell, macrophage and neutrophil accumulation. To differentiate between these 
two possibilities, the generation of a Hexb-/-CFTR-/- mouse strain would be helpful. Alter-
natively, treatment of CFTR-/- mice with the mAB NK1.1 may dissolve this issue.  
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Also other investigators have reported widespread pathology in CF mice. Increased in-
flammatory cells numbers in the lamina propria of pathogen-free raised CFTR-/- mice [32] 
and abnormal regulation of inflammation in lungs of cftr G551D mice [38] has been demon-
strated. Additionally, in comparison with age-matched wild-type littermates, alveolar archi-
tecture of Cftr-/- mice was compromised (Fig. 26) (36, 70). The authors reported on patchy 
areas of acinar dilation, typical of obstructive lung disease, in all Cftr-/- animals at all ages, 
progressive interstitial disease, and an increase in collagen and in the number of interstitial 
fibroblasts (36). They also showed the presence of “inflammatory cells in the interstitium in 
animals less than 6 months of age and alveolar macrophages. Furthermore they demon-
strated that the entire proximal and distal airways were diffusely encrusted in a thick coat-
ing of mucus-like material at all ages, which completely enveloped the ciliated surface (36, 
71). From 1 month of age, SEM of the surface of the bronchiolar epithelial cells of affected 
animals demonstrated that the cilia were embedded in this material, as were the alveolar 
walls. Morphometric determination of alveolar interstitial thickness demonstrated a signifi-
cant age-related increase in the affected animals. Type II pneumocytes were flatter than 
their wild-type counterparts and many lacked normal looking lamellar bodies (36). These 
data suggest that the basic defect in CF is also expressed in the periphery of the airways, 
i.e., the alveoli. Indeed, CFTR is expressed in rat lung alveoli in type II pneumocytes (72). 
Also results from our laboratory (M. Ulrich, unpublished) reveal the presence of CFTR in 
normal human lung tissue in type II pneumocytes. However, in the present study, neither 
NKT cells nor macrophages or neutrophils were significantly increased in alveolar sections 
of mouse lungs in comparison to the respective wild type tissues (data not shown). Simi-
larly, accumulation of cells of the innate immune system was not significantly different 
from control mice in the bronchial epithelium, where CFTR is thought to be present in cili-
ated cells (15). Thus, one can conclude that the observed accumulation of cells of the innate 
immune system in the present study is restricted to areas of highest CFTR expression, i.e., 
the submucosal glands (14).    
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Fig. 26. A: SEM of the surface of the respiratory epithelium from a terminal bronchiole in 
an 11-month-old wild-type animal. Note the numerous ciliated and nonciliated cells. B: 
Terminal bronchiole from a Cftr-/- littermate. Respiratory  epithelium is encrusted in mu-
cus-like material. C: Alveoli from the wild-type animal. D: Alveoli from the affected ani-
mal. Distal airways were caked with mucus-like material. Original magnifications: x1000 
(A, B); x650 (C, D) (from [36]). 
 
Whether the results which were obtained in CF mouse strains are also present in human 
CF patients is unclear at present. Clearly, early bacterial lung infection in CF patients con-
founds the picture of the immune response, observed in non-infected CF mice. An alterna-
tive is to investigate human fetal lung tissue. In lungs of human CF fetuses the number of 
alveolar macrophages increased during fetal development in contrast to macrophage num-
bers in human non-CF lungs (CF, 106 ± 8.0 cells/mm2; non- CF, 17 ± 11.1 cells/mm2; P < 
.001) (Fig. 27) (20). The authors hypothesized that alveolar macrophages play a prominent 
role for in the early onset of pulmonary disease in patients with CF, however, they admit 
that the nature of dysregulated signals in the local immunity generated by the CF fetal air-
ways remains to be elucidated. They also showed that the epithelial differentiation and 
maturation in CF tissues were similar to those in non-CF controls during fetal airway de-
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velopment (20), corroborating similar observations in cftrm1HGU/cftrm1HGU mice (73). 
In lungs of human CF fetuses, the submucosal glands showed “normal secretions” without 
hypertrophy and the number and distribution of mucous cells were similar in CF and non-
CF fetuses (20). The differences between these findings and the results of the present study 
may relate to the notion that submucosal glands (and CFTR) function differently before and 
after birth. Thus, in further studies it may be interesting to determine the onset of NKT cell 
accumulation in younger mice than used in the present study including murine or human 
fetuses.    
 
 
 
Fig. 27. Immunohistochemical detection of mast cells (trachea) and macrophages (lung) in 
CF and non-CF tissue sections. A, CF trachea at 36 weeks (arrows indicate mast cells). B, 
Non-CF trachea at 41 weeks. C, CF lung at 36 weeks (arrows indicate alveolar macro-
phages). D, Non-CF lung at 29 weeks. lum, Lumen; epith, surface epithelium; mes, mes-
enchyma; par, parenchyma. Bars represent 240 µm (A and B) and 120 µm (C and D) (from 
[20]). 
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Taken together, our data show that in CFTR-/- mice CD1d-restricted NKT cells accumu-
late in areas of CFTR expression in lungs and intestines. Additionally, ceramide expression 
is abnormally increased. Both ceramide and NKT cell accumulation increases with the age 
of the animals and provokes the accumulation of other cells of the innate and the adaptive 
immune system. This process can be normalized by blocking ASM which is responsible for 
the production of ceramide from sphingomyelin. Whether the inflammation provokes lung 
infection and other complications seen in the intestinal tract of CF patients is unclear at 
present.  
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5.  ABSTRACT 
 
In cystic fibrosis (CF) dysfunction of CFTR leads to pathologic changes in several or-
gans including lungs and intestine. Based on the notion that inflammation may precede 
infection in CF, the aim of this study was to investigate whether the CF defect would be 
recognized by cells of the innate immune system. Uninfected CF mouse strains and the 
respective wild type (WT) strains of different ages were used to locate and quantify NKT 
cells, macrophages and neutrophils and other immunocompetent cells in lung and intestine 
tissues. Furthermore the hypothesis was tested that ceramide accumulates in CFTR-/- cells. 
A significant increase in NKT cell numbers was observed in lung tissues of 12 week old 
CFTR-/- mice compared to WT mice. Mucin staining revealed that NKT cells accumulated 
around submucosal glands, known to express CFTR. NKT cell numbers further increased 
in 28 week old CFTR-/- mice around submucosal glands and in other parts of the lung in-
cluding the alveolar septa, suggesting that the CF defect triggers a progressive innate im-
mune response. Besides NKT cells, an accumulation of macrophages and neutrophils and 
other immunocompetent cells was observed around submucosal glands forming lympho-
cyte aggregates. In lung tissues of CFTR-/- mice, significantly increased concentrations of 
ceramide compared to control tissues were expressed in the area of submucosal glands and 
in other parts of the lung, including epithelial cells. The results suggest that defective 
CFTR provokes a high expression of ceramide which may lead to recognition by NKT cells 
possibly via endogenous glycosphingolipds. Treatment of CFTR-/- mice with amitriptyline, 
a blocker of acid sphingomyelinase, normalized the expression of ceramide and inhibited 
the clustering of NKT cells and macrophages around submucosal glands. High NKT cell 
expression was also observed in the lamina propria of jejunum, ileum and colon of CFTR-/- 
mice but not in control mice, further suggesting that the observed NKT cell recruitment in 
CFTR-/- mice is correlated to the basic CF defect. This data suggests that the basic defect 
in CF provokes an autoimmune response, characterized by ceramide over expression and 
early NKT cell accumulation around submucosal glands which thereafter is augmented and 
involved other effector cells of the innate immune system and immuocompetent cells of the 
adaptive immune system.    
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